Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03470701 · ClinicalTrials.gov registry record · NA

Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit

A NA study of Hypertension and Cardiovascular Diseases, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
999
Enrollment target
1
Study location

NCT03470701 is a NA study of Hypertension and Cardiovascular Diseases that has completed, run by Geisinger Clinic. The registered enrollment target is 999 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03470701, a NA study of Hypertension and Cardiovascular Diseases, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
999 participants
Enrollment target
1
Study location

Study Summary

This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.

Interventions

  • OTHER Mailed Urinalysis Smartphone Kit

Study Locations (1)

Pennsylvania

  • Geisinger Health System - Danville

Trial Details

FieldValue
Enrollment Target 999 participants
Start Date 2018-03-19
Est. Completion 2018-06-19
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT03470701

The ClinicalTrials.gov registry entry for NCT03470701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 999 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Mailed Urinalysis Smartphone Kit is the first listed.

NCT03470701 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03470701 about?

NCT03470701 is a clinical study titled "Improving Albuminuria Screening Compliance Using a Smartphone Urinalysis Kit". This study will test the effectiveness of mailed, smartphone urinalysis kits to improve albuminuria screening compliance and detection of albuminuria.

What is the current status of trial NCT03470701?

This trial is currently completed. It is a NA study. The enrollment target is 999 participants. The study started on 2018-03-19. Estimated completion is 2018-06-19.

What conditions does trial NCT03470701 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Chronic Kidney Diseases, Albuminuria.

What interventions are being tested in trial NCT03470701?

The interventions under investigation include: Mailed Urinalysis Smartphone Kit (OTHER).

Who is sponsoring clinical trial NCT03470701?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03470701 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.